검색결과 : 7건
| No. | Article |
|---|---|
| 1 |
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus Ma HM, Kim AS, Kafai NM, Earnest JT, Shah AP, Case JB, Basore K, Gilliland TC, Sun CQ, Nelson CA, Thackray LB, Klimstra WB, Fremont DH, Diamond MS Nature, 588(7837), 308, 2020 |
| 2 |
Potently neutralizing and protective human antibodies against SARS-CoV-2 Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RTE, Nkolola JP, Schafer A, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Martinez DR, Williamson LE, Chen EEC, Jones T, Day S, Myers L, Hassan AO, Kafai NM, Winkler ES, Fox JM, Shrihari S, Mueller BK, Meiler J, Chandrashekar A, Mercado NB, Steinhardt JJ, Ren KS, Loo YM, Kallewaard NL, McCune BT, Keeler SP, Holtzman MJ, Barouch DH, Gralinski LE, Baric RS, Thackray LB, Diamond MS, Carnahan RH, Crowe JE Nature, 584(7821), 443, 2020 |
| 3 |
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus Ma HM, Kim AS, Kafai NM, Earnest JT, Shah AP, Case JB, Basore K, Gilliland TC, Sun CQ, Nelson CA, Thackray LB, Klimstra WB, Fremont DH, Diamond MS Nature, 588(7837), 308, 2020 |
| 4 |
Potently neutralizing and protective human antibodies against SARS-CoV-2 Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RTE, Nkolola JP, Schafer A, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Martinez DR, Williamson LE, Chen EEC, Jones T, Day S, Myers L, Hassan AO, Kafai NM, Winkler ES, Fox JM, Shrihari S, Mueller BK, Meiler J, Chandrashekar A, Mercado NB, Steinhardt JJ, Ren KS, Loo YM, Kallewaard NL, McCune BT, Keeler SP, Holtzman MJ, Barouch DH, Gralinski LE, Baric RS, Thackray LB, Diamond MS, Carnahan RH, Crowe JE Nature, 584(7821), 443, 2020 |
| 5 |
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RTE, Havenar-Daughton C, Snell G, Telenti A, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D Nature, 583(7815), 290, 2020 |
| 6 |
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms Tortorici MA, Beltramello M, Lempp FA, Pinto D, Dang HV, Rosen LE, McCallum M, Bowen J, Minola A, Jaconi S, Zatta F, De Marco A, Guarino B, Bianchi S, Lauron EJ, Tucker H, Zhou JY, Peter A, Havenar-Daughton C, Wojcechowskyj JA, Case JB, Chen RE, Kaiser H, Montiel-Ruiz M, Meury M, Czudnochowski N, Spreafico R, Dillen J, Ng C, Sprugasci N, Culap K, Benigni F, Abdelnabi R, Foo SYC, Schmid MA, Cameroni E, Riva A, Gabrieli A, Galli M, Pizzuto MS, Neyts J, Diamond MS, Virgin HW, Snell G, Corti D, Fink K, Veesler D Science, 370(6519), 950, 2020 |
| 7 |
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors Cao LX, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D Science, 370(6515), 426, 2020 |